EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) Fundamental Analysis & Valuation

TSX-V:EVMT • CA30053H1055

Current stock price

0.005 CAD
0 (0%)
Last:

This EVMT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EVMT.CA Profitability Analysis

1.1 Basic Checks

  • In the past year EVMT has reported negative net income.
  • EVMT had a positive operating cash flow in the past year.
  • In the past 5 years EVMT always reported negative net income.
  • In the past 5 years EVMT reported 4 times negative operating cash flow.
EVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFEVMT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

  • With a decent Return On Assets value of -66.99%, EVMT is doing good in the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROIC N/A
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
EVMT.CA Yearly ROA, ROE, ROICEVMT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

  • EVMT has a Gross Margin of 33.80%. This is in the lower half of the industry: EVMT underperforms 62.50% of its industry peers.
  • EVMT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EVMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
EVMT.CA Yearly Profit, Operating, Gross MarginsEVMT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EVMT.CA Health Analysis

2.1 Basic Checks

  • EVMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EVMT has more shares outstanding
  • The debt/assets ratio for EVMT is higher compared to a year ago.
EVMT.CA Yearly Shares OutstandingEVMT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
EVMT.CA Yearly Total Debt VS Total AssetsEVMT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

  • EVMT has an Altman-Z score of -2.59. This is a bad value and indicates that EVMT is not financially healthy and even has some risk of bankruptcy.
  • EVMT's Altman-Z score of -2.59 is fine compared to the rest of the industry. EVMT outperforms 62.50% of its industry peers.
  • EVMT has a debt to FCF ratio of 3.25. This is a good value and a sign of high solvency as EVMT would need 3.25 years to pay back of all of its debts.
  • EVMT's Debt to FCF ratio of 3.25 is amongst the best of the industry. EVMT outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Altman-Z -2.59
ROIC/WACCN/A
WACC8.49%
EVMT.CA Yearly LT Debt VS Equity VS FCFEVMT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that EVMT may have some problems paying its short term obligations.
  • With a Current ratio value of 0.51, EVMT is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • EVMT has a Quick Ratio of 0.51. This is a bad value and indicates that EVMT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EVMT has a Quick ratio of 0.24. This is in the lower half of the industry: EVMT underperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
EVMT.CA Yearly Current Assets VS Current LiabilitesEVMT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. EVMT.CA Growth Analysis

3.1 Past

  • EVMT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.50%.
  • EVMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.95%.
  • Measured over the past years, EVMT shows a very strong growth in Revenue. The Revenue has been growing by 73.88% on average per year.
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVMT.CA Yearly Revenue VS EstimatesEVMT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EVMT.CA Yearly EPS VS EstimatesEVMT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

Find the best growth stocksShow best growing peers

2

4. EVMT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVMT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVMT.CA Price Earnings VS Forward Price EarningsEVMT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than EVMT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.06
EV/EBITDA N/A
EVMT.CA Per share dataEVMT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVMT.CA Dividend Analysis

5.1 Amount

  • No dividends for EVMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EVMT.CA Fundamentals: All Metrics, Ratios and Statistics

EVOME MEDICAL TECHNOLOGIES I

TSX-V:EVMT (5/6/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07
Earnings (Next)08-11
Inst Owners9.89%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap300.85K
Revenue(TTM)48.34M
Net Income(TTM)-23.53M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.06
P/OCF 0.06
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.09
FCFY1784.34%
OCF(TTM)0.09
OCFY1796.34%
SpS0.8
BVpS-0.06
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.8%
FCFM 11.1%
ROA(3y)-20.97%
ROA(5y)-17.84%
ROE(3y)-154.4%
ROE(5y)-98.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-27.65%
GM growth 5YN/A
F-Score3
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.25
Debt/EBITDA N/A
Cap/Depr 1.09%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -2.59
F-Score3
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.22%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-140%
EPS Next Y-400%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.95%
Revenue growth 3Y438.98%
Revenue growth 5Y73.88%
Sales Q2Q%-49.05%
Revenue Next Year-0.65%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y434.86%
OCF growth 3YN/A
OCF growth 5YN/A

EVOME MEDICAL TECHNOLOGIES I / EVMT.CA Fundamental Analysis FAQ

What is the fundamental rating for EVMT stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVMT.CA.


What is the valuation status of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to EVOME MEDICAL TECHNOLOGIES I (EVMT.CA). This can be considered as Overvalued.


How profitable is EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) stock?

EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for EVMT stock?

The financial health rating of EVOME MEDICAL TECHNOLOGIES I (EVMT.CA) is 2 / 10.